Podcast: Play in new window | Download (Duration: 16:10 — 14.8MB) | Embed

Subscribe: Spotify | iHeartRadio | Blubrry | TuneIn | Deezer | RSS | More

Thanks to David Einstein, MD, from Beth Israel Deaconess Medical Center, for discussing “Into the Unknown: How Do We Study Prostate Cancer Treatments, ” For every exciting new therapy, there is a long road of research along which many other strategies have been abandoned. In this podcast, Dr. Einstein outlines the process of identifying new treatment strategies in the lab, “translating” these into clinical trials, and developing them into standard-of-care treatments. Dr. Einstein will explore this topic in more detail on the May 14 virtual symposium, hosted by MPCC. Click here to learn more about the Massachusetts Prostate Cancer Coalition.

Podcast: Play in new window | Download (Duration: 16:40 — 15.3MB) | Embed

Subscribe: Spotify | iHeartRadio | Blubrry | TuneIn | Deezer | RSS | More

Thanks to Christina Dieli-Conwright, PhD, MPH, Dana-Farber Cancer Institute for discussing “Exercise as Medicine for Prostate Cancer Survivorship.” Persons at risk and diagnosed with prostate cancer are a vulnerable population in need of non-pharmacologic interventions to improve health outcomes. Using an “Exercise as Medicine” approach, intervention studies demonstrate that exercise can improve comorbid conditions and prostate cancer treatment-related side effects. Dr. Dieli-Conwright will explore this topic in more detail on the May 14 virtual symposium, hosted by MPCC. Click here to learn more about the Massachusetts Prostate Cancer Coalition.